Elevated COVID19 mortality risk in Detroit area hospitals among patients from census tracts with extreme socioeconomic vulnerability

Abstract

Background the incidence of novel coronavirus disease (COVID19) is elevated in areas with heightened socioeconomic vulnerability. Early reports from US hospitals also implicated social disadvantage and chronic disease history as COVID19 mortality risk factors. However, the relationship between race and COVID19 mortality remains unclear. Methods we examined in-hospital COVID19 mortality risk factors in a multi-hospital tertiary health care system that serves greater Detroit, Michigan, a predominantly African American city with high rates of poverty and chronic disease. Consecutive adult patients who presented to emergency departments and tested positive for COVID19 from 3/11/2020 through 4/18/2020 were included. Using log-binomial regression, we assessed the relationship between in-hospital mortality and residence in census tracts that were flagged for extreme socioeconomic vulnerability, patient-level demographics, and clinical comorbidities. Findings a total of 1,015 adults tested positive for COVID19 during the study period; 80% identified as Black people, 52% were male and 53% were ≥ 65 years of age. The median body mass index was 30•4 and the median Charlson Comorbidity Index score was 4. Patients from census tracts that were flagged for vulnerability related to socioeconomic status had a higher mortality rate than their peers who resided in less vulnerable census tracts (β 0.26, standard error (SE) 0.11, degrees of freedom (df) 378, t -value ( t ) 2.27, exp(β) 1.29, p -value 0.02). Adjustment for age category, Black race, sex and/or the Charlson Comorbidity Index score category reduced the magnitude of association by less than 10% [exp(β) 1.29 vs. 1.21]. Black race [ p = 0.38] and sex [ p = 0.62] were not associated with mortality in this sample. Interpretation people who lived in areas flagged for extreme socioeconomic vulnerability had elevated mortality risk in our predominantly African-American cohort of COVID19 patients who were able to seek hospital care during the so-called ‘first wave’ of the pandemic. By contrast, Black race was not associated with mortality in our sample.

Demographic Characteristics, Comorbidities, and Length of Stay of COVID-19 Patients Admitted Into Intensive Care Units in Saudi Arabia: A Nationwide Retrospective Study

“…Multiple linear regression models were performed to examine the impact of age, gender, and different comorbidities on the recovery period, LOS in ICU and hospital admission. In addition, the Charlson Comorbidity Index (CCI) was assessed to predict a 10-year survival rate in patients with comorbidities and was used as a measure of the total comorbidity burden ( 13 ). The SPSS v.23 (IBM Statistics, Armonk, NJ) tool was used for statistical data analysis.…”

Social Determinants of Health Correlating with Mechanical Ventilation of COVID-19 Patients: A Multi-Center Observational Study

“…COVID-19 burden has been similarly observed in regions scoring high on the Distressed Communities Index, including Detroit. 7,8 Zhang et al further demonstrated that NYC neighborhoods with disadvantaged social conditions (low socioeconomic status, non-white, elderly) had higher mortality rates from COVID-19. 9 Under conditions of crowded living, public transport, and frontline work, transmission is more likely.…”

Impact of Social Determinants on the Burden of Asthma and Eczema: Results from a US Patient Survey

“…A study of COVID-19 cases in a California integrated health system found that Black patients had a 2.7-times higher likelihood of hospitalization than non-Hispanic White patients after controlling for age, sex, comorbidities, and income [19]. Furthermore, social and economic vulnerability is significantly associated with COVID-19 incidence and mortality [20,21]. Racism and provider bias in the healthcare system are causes for healthcare disparities that are beginning to be explored for asthma and eczema [22][23][24][25].…”